| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/25/2003 | US20030180328 Forming vaccines; analyzing hemagglutinin, calibration |
| 09/25/2003 | US20030180327 Veterinary medicine; induce immunology response |
| 09/25/2003 | US20030180326 Methods and compositions for impairing multiplication of HIV-1 |
| 09/25/2003 | US20030180322 Genome segments; detection of phenotype |
| 09/25/2003 | US20030180320 Dna vaccines; genetic engineering; eukaroytic gene expression; screening libraries |
| 09/25/2003 | US20030180319 Mutant bacteriophages; genetic engineering |
| 09/25/2003 | US20030180317 Diagnosis ear infections in children |
| 09/25/2003 | US20030180316 Mixture of pertussis, tetanyus, diphtheria toxins |
| 09/25/2003 | US20030180315 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 09/25/2003 | US20030180314 Genetic engineering polypeptide; culture product |
| 09/25/2003 | US20030180312 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180309 Autoimmune disease; antiinflammatory agents; antiallergens; antihistamines; d |
| 09/25/2003 | US20030180308 Deglycosylated ricin toxin a-chain vaccine |
| 09/25/2003 | US20030180307 Polypeptides; detecting infections using antibodies |
| 09/25/2003 | US20030180304 Enzyme inhibitor; tuberculosis therapy |
| 09/25/2003 | US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation |
| 09/25/2003 | US20030180298 Genetic engineering; using nucleic acid for cancer diagnosis |
| 09/25/2003 | US20030180296 Antibodies that immunospecifically bind to trail receptors |
| 09/25/2003 | US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 09/25/2003 | US20030180294 Administering vascular endothelial growth factor receptor inhibitor; supression lymphangiogenesis |
| 09/25/2003 | US20030180293 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 09/25/2003 | US20030180292 Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy |
| 09/25/2003 | US20030180290 Anti-CD80 antibody having ADCC activity for ADCC mediated killing of B cell lymphoma cells alone or in combination with other therapies |
| 09/25/2003 | US20030180285 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti hsp90 antibodies |
| 09/25/2003 | US20030180284 Monoclonal antibodies; vaccines |
| 09/25/2003 | US20030180265 Modulating angiogenesis |
| 09/25/2003 | US20030180260 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor |
| 09/25/2003 | US20030180257 Alphavirus vectors for paramyxovirus vaccines |
| 09/25/2003 | US20030180225 Walnut and ryegrass allergens |
| 09/25/2003 | US20030180219 Calibrating efficiency of vaccines |
| 09/25/2003 | CA2479315A1 Improvements in vaccination |
| 09/25/2003 | CA2479307A1 Virus like particle from papillomavirus and their use in vaccine |
| 09/25/2003 | CA2479304A1 Virus-like particles of human papillomavirus |
| 09/25/2003 | CA2479212A1 Central airway administration for systemic delivery of therapeutics |
| 09/25/2003 | CA2479187A1 Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response |
| 09/25/2003 | CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 09/25/2003 | CA2478973A1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 09/25/2003 | CA2478803A1 Methods of modulating cd200 receptors |
| 09/25/2003 | CA2478651A1 Method of inducing an enhanced immune response against hiv |
| 09/25/2003 | CA2478248A1 Methods and devices for detection and therapy of atheromatous plaque |
| 09/25/2003 | CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/24/2003 | EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 09/24/2003 | EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage |
| 09/24/2003 | EP1346730A1 Pretargeting methods and novel pretargeting conjugates |
| 09/24/2003 | EP1346727A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 09/24/2003 | EP1346218A1 Tripeptide of fc gama riia |
| 09/24/2003 | EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol |
| 09/24/2003 | EP1346049A2 EFFICIENT EXPRESSION OF i PLASMODIUM /i APICAL MEMBRANE ANTIGEN 1 IN YEAST CELLS |
| 09/24/2003 | EP1346036A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 09/24/2003 | EP1345969A2 Anti-cd28 antibody |
| 09/24/2003 | EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/24/2003 | EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 09/24/2003 | EP1345694A2 A method for the manufacture of compositions containing low concentrations of salts |
| 09/24/2003 | EP1345658A2 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
| 09/24/2003 | EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 09/24/2003 | EP1345624A1 Induction of tolerance |
| 09/24/2003 | EP1345623A2 Immunogenic proteoliposomes, and uses thereof |
| 09/24/2003 | EP1345622A2 Eiav chimeric vaccine and diagnostic |
| 09/24/2003 | EP1345621A1 i SALMONELLA /i VACCINE |
| 09/24/2003 | EP1345618A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 09/24/2003 | EP1345617A2 Methods of modulating toll-related receptor (trr) signaling |
| 09/24/2003 | EP1345615A1 Use of tinospora extract in the treatment of immune system-modulated disorders |
| 09/24/2003 | EP1345574A2 Improvement of graft acceptance through manipulation of thymic regeneration |
| 09/24/2003 | EP1206482B1 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 09/24/2003 | EP0975359B1 Use of compounds binding a cytoplasmic dipeptidase for the potentiation of the immune response |
| 09/24/2003 | EP0785713B1 Creating an aerosolized formulation of insulin |
| 09/24/2003 | EP0764048B1 Chromatography adsorbents utilizing mercapto heterocyclic ligands |
| 09/24/2003 | CN1444648A Method of amplifying natural killer T cells |
| 09/24/2003 | CN1444601A Regulating lipid levels via the Zmaxl or HBM gene |
| 09/24/2003 | CN1444598A Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of immune response to amyloid beta and amyloid deposits |
| 09/24/2003 | CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor |
| 09/24/2003 | CN1444477A Thrombopoietin mimetics |
| 09/24/2003 | CN1444474A Nonoral preparation having three-layer structure |
| 09/24/2003 | CN1443844A Hepatitis A virus strain, method for preparing hepatitis A inactivated vaccine and obtained vaccine |
| 09/24/2003 | CN1443778A Monoclonal antibody of melanic related antigen, and its application and medicine composition |
| 09/24/2003 | CN1443777A Monoclonal antibody capable of identifying tumor cell surface antigen and its preparation and application |
| 09/24/2003 | CN1443775A Leptospira outer membrane protein and its code sequence |
| 09/24/2003 | CN1122108C Immunogenic peptides of foot and mouth disease viruses |
| 09/24/2003 | CN1122105C Novel method viruses, anti viral compounds and novel methods of making vaccines |
| 09/24/2003 | CN1121874C Immunotherapeutic agent and its use |
| 09/24/2003 | CN1121817C Immunity dairy products of prevention of human body alimentary canal pathogeny microorganism |
| 09/23/2003 | US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents |
| 09/23/2003 | US6624141 Protamine fragment compositions and methods of use |
| 09/23/2003 | US6623952 Infectious; of given sequence; may be used as a vector for gene therapy, in a vaccine or for detection of viruses for xenotransplantation |
| 09/23/2003 | US6623923 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 09/23/2003 | US6623764 Biodegradable targetable microparticle delivery system |
| 09/23/2003 | US6623762 Simple non-toxic system, deliverable by syringe or needle-free systems, is inexpensive and reliable and aids in parenteral drug delivery or mass immunization campaigns by reducing need for repeated injections |
| 09/23/2003 | US6623740 Peptide having an amino acid sequence set forth in SEQ ID NO: 3, 5, 9, 11, 13, 14 or 15 |
| 09/23/2003 | US6623739 Oil-in-water emulsions containing metabolizable oil and alpha tocopherol; enhancing immune responses to given antigen |
| 09/23/2003 | US6623735 Vaccine containing a thiol protease |
| 09/23/2003 | US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis |
| 09/23/2003 | CA2164818C Tandem synthetic hiv-1 peptides |
| 09/23/2003 | CA2139518C Antigenic regions of tlp complexes and antibodies against the same |
| 09/23/2003 | CA2112907C Peptide which abrogates tnf and/or lps toxicity |
| 09/23/2003 | CA2101332C Antibody polycation conjugates |
| 09/23/2003 | CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 09/23/2003 | CA1341439C Feline t-lymphotropic lentivirus |
| 09/20/2003 | CA2377608A1 Tet-transactivator system |
| 09/18/2003 | WO2003076948A1 Use of the mal protein as a tumour marker |
| 09/18/2003 | WO2003076898A2 Mycobacterial diagnostics |